Many studies have shown that CDC25C is highly expressed in lung [3, 4], liver [5], gastric [6], bladder [7], prostate [8, 9], esophageal [10], and colorectal cancers [11] and in acute myeloid leukemia [12], correlated to poor prognosis and low survival rates. Here, CDC25C is linked to acute myeloid leukemia.